UPDATED Apr 15, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ENOV | US$56.81 | -7.9% | 2.2% | US$3.2b | US$75.20 | PS1.8x | E83.1% | n/a | ||
HIMS | US$13.22 | -11.2% | 32.6% | US$3.0b | US$15.10 | PS3.2x | E44.9% | n/a | ||
GDRX | US$6.55 | -4.2% | 13.1% | US$2.6b | US$8.68 | PS3.3x | E40.4% | n/a | ||
SGRY | US$25.67 | -6.1% | -30.4% | US$3.3b | US$42.36 | PS1.2x | E46.3% | n/a | ||
AMED | US$91.35 | -1.1% | 15.6% | US$3.0b | US$97.78 | PS1.3x | E61.6% | n/a | ||
NVST | US$19.14 | -5.8% | -49.2% | US$3.3b | US$24.27 | PS1.3x | E67.9% | n/a | ||
EVH | US$30.30 | -0.7% | -10.8% | US$3.4b | US$45.23 | PS1.8x | E60.0% | n/a | ||
CERT | US$17.44 | -7.9% | -27.3% | US$2.8b | US$19.74 | PS7.9x | E109.0% | n/a | ||
INSP | US$223.14 | -2.2% | -16.1% | US$7.0b | US$251.69 | PS10.8x | E50.3% | n/a | ||
NARI | US$39.49 | -7.6% | -39.6% | US$2.4b | US$73.00 | PS4.6x | E55.7% | n/a | ||
AXNX | US$67.33 | -0.6% | 15.4% | US$3.4b | US$71.80 | PS9.4x | E43.5% | n/a | ||
IRTC | US$109.48 | -3.1% | -18.1% | US$3.5b | US$138.50 | PS6.9x | E66.0% | n/a | ||
TDOC | US$13.55 | -7.3% | -47.6% | US$2.4b | US$19.91 | PB1x | E47.7% | n/a | ||
CVET | US$20.99 | 0.5% | 5.6% | US$2.9b | US$21.50 | PB2x | S5.6% | n/a | ||
TNDM | US$31.86 | -5.0% | -23.7% | US$2.2b | US$34.64 | PS2.8x | E64.9% | n/a | ||
PRCT | US$50.60 | 2.4% | 36.9% | US$2.6b | US$56.67 | PS18.9x | E37.0% | n/a |